
Natasha N. Campbell
Examiner (ID: 9346, Phone: (571)270-7382 , Office: P/1714 )
| Most Active Art Unit | 1714 |
| Art Unit(s) | 1792, 1714 |
| Total Applications | 931 |
| Issued Applications | 574 |
| Pending Applications | 75 |
| Abandoned Applications | 300 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10738705
[patent_doc_number] => 20160084856
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-03-24
[patent_title] => 'HDL-ASSOCIATED PROTEIN EXTRACTION AND DETECTION'
[patent_app_type] => utility
[patent_app_number] => 14/858111
[patent_app_country] => US
[patent_app_date] => 2015-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 4303
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14858111
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/858111 | HDL-associated protein extraction and detection | Sep 17, 2015 | Issued |
Array
(
[id] => 11040160
[patent_doc_number] => 20160237117
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-18
[patent_title] => 'CONNECTIVE TISSUE STIMULATING PEPTIDES'
[patent_app_type] => utility
[patent_app_number] => 14/854238
[patent_app_country] => US
[patent_app_date] => 2015-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 12384
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14854238
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/854238 | Connective tissue stimulating peptides | Sep 14, 2015 | Issued |
Array
(
[id] => 11969914
[patent_doc_number] => 20170274068
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-28
[patent_title] => 'IMMUNOLOGICAL REAGENT'
[patent_app_type] => utility
[patent_app_number] => 15/509997
[patent_app_country] => US
[patent_app_date] => 2015-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 6484
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15509997
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/509997 | IMMUNOLOGICAL REAGENT | Sep 10, 2015 | Abandoned |
Array
(
[id] => 11743942
[patent_doc_number] => 20170198014
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-13
[patent_title] => 'POLYPEPTIDES AND THEIR USE FOR TREATING INFLUENZA'
[patent_app_type] => utility
[patent_app_number] => 15/320936
[patent_app_country] => US
[patent_app_date] => 2015-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 22941
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15320936
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/320936 | POLYPEPTIDES AND THEIR USE FOR TREATING INFLUENZA | Aug 25, 2015 | Abandoned |
Array
(
[id] => 10693733
[patent_doc_number] => 20160039880
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-02-11
[patent_title] => 'CYCLOSPORIN A ANALOGS'
[patent_app_type] => utility
[patent_app_number] => 14/824392
[patent_app_country] => US
[patent_app_date] => 2015-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39207
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14824392
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/824392 | CYCLOSPORIN A ANALOGS | Aug 11, 2015 | Abandoned |
Array
(
[id] => 10458002
[patent_doc_number] => 20150343017
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-03
[patent_title] => 'CYCLOSPORIN COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 14/822682
[patent_app_country] => US
[patent_app_date] => 2015-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13412
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14822682
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/822682 | CYCLOSPORIN COMPOSITIONS | Aug 9, 2015 | Abandoned |
Array
(
[id] => 11388741
[patent_doc_number] => 09549972
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-01-24
[patent_title] => 'MHC-I restricted epitopes containing non-natural amino acid residues'
[patent_app_type] => utility
[patent_app_number] => 14/820194
[patent_app_country] => US
[patent_app_date] => 2015-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25602
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14820194
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/820194 | MHC-I restricted epitopes containing non-natural amino acid residues | Aug 5, 2015 | Issued |
Array
(
[id] => 13675145
[patent_doc_number] => 20160376306
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-29
[patent_title] => N-Terminally Modified Linear and Branched Polyamine Conjugated Peptidomimetics as Antimicrobials Agents
[patent_app_type] => utility
[patent_app_number] => 14/754002
[patent_app_country] => US
[patent_app_date] => 2015-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6459
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 135
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14754002
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/754002 | N-terminally modified linear and branched polyamine conjugated peptidomimetics as antimicrobials agents | Jun 28, 2015 | Issued |
Array
(
[id] => 11779143
[patent_doc_number] => 09388238
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-07-12
[patent_title] => 'Modulation of synaptic maintenance'
[patent_app_type] => utility
[patent_app_number] => 14/751849
[patent_app_country] => US
[patent_app_date] => 2015-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 30
[patent_no_of_words] => 16091
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14751849
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/751849 | Modulation of synaptic maintenance | Jun 25, 2015 | Issued |
Array
(
[id] => 11773475
[patent_doc_number] => 09382313
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-07-05
[patent_title] => 'Modulation of synaptic maintenance'
[patent_app_type] => utility
[patent_app_number] => 14/751921
[patent_app_country] => US
[patent_app_date] => 2015-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 29
[patent_no_of_words] => 16096
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14751921
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/751921 | Modulation of synaptic maintenance | Jun 25, 2015 | Issued |
Array
(
[id] => 11773476
[patent_doc_number] => 09382314
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-07-05
[patent_title] => 'Modulation of synaptic maintenance'
[patent_app_type] => utility
[patent_app_number] => 14/751967
[patent_app_country] => US
[patent_app_date] => 2015-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 30
[patent_no_of_words] => 16097
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14751967
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/751967 | Modulation of synaptic maintenance | Jun 25, 2015 | Issued |
Array
(
[id] => 11804470
[patent_doc_number] => 09545434
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-01-17
[patent_title] => 'Treatment of short bowel syndrome patients with colon-in-continuity'
[patent_app_type] => utility
[patent_app_number] => 14/745157
[patent_app_country] => US
[patent_app_date] => 2015-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7089
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14745157
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/745157 | Treatment of short bowel syndrome patients with colon-in-continuity | Jun 18, 2015 | Issued |
Array
(
[id] => 10399692
[patent_doc_number] => 20150284701
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-08
[patent_title] => 'FUSION PROTEINS OF COLLAGEN-BINDING DOMAIN AND PARATHYROID HORMONE'
[patent_app_type] => utility
[patent_app_number] => 14/743629
[patent_app_country] => US
[patent_app_date] => 2015-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 12891
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14743629
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/743629 | Fusion proteins of collagen-binding domain and parathyroid hormone | Jun 17, 2015 | Issued |
Array
(
[id] => 11506137
[patent_doc_number] => 09597274
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-03-21
[patent_title] => 'Peptides and their use in the treatment of skin'
[patent_app_type] => utility
[patent_app_number] => 14/742060
[patent_app_country] => US
[patent_app_date] => 2015-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23958
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14742060
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/742060 | Peptides and their use in the treatment of skin | Jun 16, 2015 | Issued |
Array
(
[id] => 15468571
[patent_doc_number] => 10550148
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-02-04
[patent_title] => Methods for increasing the capacity of flow-through processes
[patent_app_type] => utility
[patent_app_number] => 14/736596
[patent_app_country] => US
[patent_app_date] => 2015-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 2798
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14736596
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/736596 | Methods for increasing the capacity of flow-through processes | Jun 10, 2015 | Issued |
Array
(
[id] => 16428309
[patent_doc_number] => 10828370
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-11-10
[patent_title] => Selectin and ICAM/VCAM peptide ligand conjugates
[patent_app_type] => utility
[patent_app_number] => 15/310416
[patent_app_country] => US
[patent_app_date] => 2015-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 18197
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15310416
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/310416 | Selectin and ICAM/VCAM peptide ligand conjugates | May 11, 2015 | Issued |
Array
(
[id] => 10676618
[patent_doc_number] => 20160022763
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-28
[patent_title] => 'COMPOSITIONS AND METHODS FOR INHIBITING CELLULAR ADHESION OR DIRECTING DIAGNOSTIC OR THERAPEUTIC AGENTS TO RGD BINDING SITES'
[patent_app_type] => utility
[patent_app_number] => 14/696250
[patent_app_country] => US
[patent_app_date] => 2015-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 13421
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14696250
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/696250 | Compositions and methods for inhibiting cellular adhesion or directing diagnostic or therapeutic agents to RGD binding sites | Apr 23, 2015 | Issued |
Array
(
[id] => 10333230
[patent_doc_number] => 20150218234
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-06
[patent_title] => 'Extracting Hirudin from Leech in vivo'
[patent_app_type] => utility
[patent_app_number] => 14/691381
[patent_app_country] => US
[patent_app_date] => 2015-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5009
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14691381
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/691381 | Extracting hirudin from leech in vivo | Apr 19, 2015 | Issued |
Array
(
[id] => 10290667
[patent_doc_number] => 20150175665
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-25
[patent_title] => 'ANALOGUES OF GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE (GIP) MODIFIED AT N-TERMINAL'
[patent_app_type] => utility
[patent_app_number] => 14/639210
[patent_app_country] => US
[patent_app_date] => 2015-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16003
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14639210
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/639210 | ANALOGUES OF GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE (GIP) MODIFIED AT N-TERMINAL | Mar 4, 2015 | Abandoned |
Array
(
[id] => 10279985
[patent_doc_number] => 20150164982
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-18
[patent_title] => 'CYCLOSPORIN COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 14/635734
[patent_app_country] => US
[patent_app_date] => 2015-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13515
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14635734
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/635734 | CYCLOSPORIN COMPOSITIONS | Mar 1, 2015 | Abandoned |